2 HOLTZMAN ST., SCIENCE PARK, REHOVOT, L3
Updates on Withholding Tax Procedures on Previously Announced Cash Dividend to Shareholders
Declares Cash Dividend of $0.17 Per Share
Kamada Reports Record-High 2026 Financial Results and Growth
Holds Annual General Meeting of Shareholders
To Announce Second Quarter and First Half Ended June 30, 2026 Financial Results on August 12, 2026
Announces a Three-Year $50 Million Sales Agreement to Supply Plasma to a Leading Biopharmaceutical Company Focused on Plasma-Derived Therapies
Highlights CYTOGAM® Study Results Presented at the 2026 ISHLT Annual Meeting
Annual General Meeting of Shareholders on August 5, 2026
Annual and Transition Report of Foreign Private Issuers
Amended Annual and Transition Report of Foreign Private Issuers
Effectiveness Notice
Registration Statement for Securities of Certain Foreign Private Issuers and Certain Canadian Issuers, Offered on a Continuous Basis
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
No filings found
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Correspondence
Submission Upload
Confidential Treatment Order